Clinical trials
Recruiting Phase 1 Neurodegenerative Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Alnylam Pharmaceuticals | 1 |
| Novabio Therapeutics | 1 |
| University of California, San Diego | 1 |
| University of Nicosia | 1 |
| University of Texas Southwestern Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodegenerative Diseases | 7 |
| Alzheimer Disease | 3 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Cognitive Dysfunction | 2 |
| Dementia | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Ataxia | 1 |
| Dyskinesias | 1 |
| Giant Axonal Neuropathy | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.